+1 (202) 780-33974th International Conference on HEMATOLOGY AND BONE MARROW TRANSPLANTATION
July 25-26, 2019 | Amsterdam, Netherlands
Keynote
-
SCIENTIFIC RATIONALE FOR LOWER DOSE OF IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
Hematol Blood Disord
Varsha Gandhi -
TRANSLATION OF PVSG/WHO INTO THE CLINICAL, LABORATORY, MOLECULAR AND PATHOLOGICAL (2018 CLMP) DEFINED MYELOPROLIFERATIVE NEOPLASMS CAUSED BY JAK2V617F JAK2EXON12, CALR, MPL AND TPO DRIVER MUTATIONS ARE DISTINCT BLOOD AND COAGULATION DISORDERS: PROGNOSTIC AND THERAPEUTIC IMPLICATIONS TOWARDS 2020 AND BEYOND
Hematol Blood Disord
Jan Jacques Michiels